Oral small-molecule GLP-1RA safiglipron versus dapagliflozin in type 2 diabetes: a randomized, double-blind, active-comparator-controlled phase 3 trial
科研动态Nature Medicine
2026-10-05
Safiglipron is an oral small-molecule glucagon-like peptide-1 (GLP-1) receptor agonist administered without fasting or d…
原文：Nature Medicine（本页为平台整理的中文摘要，逐句对照原文核对后发布）